Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NIH Grants Awarded to Vanderbilt, Morehouse, and More

Premium

NIH Grants in Proteomics, March 15 to April 17

Project Title: Regulatory Pathways of SR Protein Kinases
Contact Principal Investigator: Joseph Adams
Organization Name: University of California San Diego
Project Start Date: Feb. 1, 2004
Project End Date: Dec. 31, 2016
FY Total Cost: $310,000


Project Title: Clk Kinases and Splicing Regulation
Contact Principal Investigator: Joseph Adams
Organization Name: University of California San Diego
Project Start Date: June 1, 2012
Project End Date: March 31, 2016
FY Total Cost: $265,050


Project Title: Induced Pluripotent Stem Cells for the Study of Long QT Syndrome
Contact Principal Investigator: Eric Adler
Organization Name: University of California San Diego
Project Start Date: April 18, 2011
Project End Date: March 31, 2016
FY Total Cost: $133,650


Project Title: Molecular and Cellular Basis of Obesity Core
Contact Principal Investigator: David Bernlohr
Organization Name: University of Minnesota
Project Start Date: NA
Project End Date: NA
FY Total Cost: $262,935


Project Title: Instrumentation Development: MS Array for Quantitative Proteomics
Contact Principal Investigator: James Bruce
Organization Name: University of Washington
Project Start Date: April 1, 2011
Project End Date: March 31, 2015
FY Total Cost: $294,110


Project Title: Dissecting the Cytoplasmic Interactome of The Alpha7 NAChR Subtype
Contact Principal Investigator: William Brucker
Organization Name: Brown University
Project Start Date: April 1, 2008
Project End Date: March 31, 2014
FY Total Cost: $47,232


Project Title: Chemoproteomic Methods for Serine Hydrolase Inhibitor Development
Contact Principal Investigator: Benjamin Cravatt
Organization Name: Scripps Research Institute
Project Start Date: April 1, 2012
Project End Date: March 31, 2017
FY Total Cost: $443,210


Project Title: Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
Contact Principal Investigator: Todd Fehniger
Organization Name: Washington University
Project Start Date: April 26, 2009
Project End Date: March 31, 2014
FY Total Cost: $116,503


Project Title: Proteomics Facility Core
Contact Principal Investigator: Peter Guengerich
Organization Name: Vanderbilt University Medical Central
Project Start Date: NA
Project End Date: NA
FY Total Cost: $112,418


Project Title: Global Characterization of Ubiquitin Information Networks with Mass Spectrometry
Contact Principal Investigator: Steven Gygi
Organization Name: Harvard University Medical School
Project Start Date: May 15, 2003
Project End Date: Feb. 28, 2017
FY Total Cost: $457,282


Project Title: A Molecular Toolkit for Single-Molecule Protein Sequencing
Contact Principal Investigator: James Havranek
Organization Name: Washington University
Project Start Date: June 1, 2012
Project End Date: March 31, 2017
FY Total Cost: $259,920


Project Title: Cardioprotective Mechanisms of HDL
Contact Principal Investigator: Jay Heinecke
Organization Name: University of Washington
Project Start Date: April 16, 2012
Project End Date: March 31, 2016
FY Total Cost: $390,938


Project Title: Chemical Inhibitors to Define an Essential M. Tuberculosis Signaling Network
Contact Principal Investigator: Robert Husson
Organization Name: Childrens Hospital Corporation
Project Start Date: April 16, 2012
Project End Date: March 31, 2017
FY Total Cost: $1,093,417


Project Title: Reactive Species in Vascular Disease: Mechanisms of Injury
Contact Principal Investigator: Harry Ischiropoulos
Organization Name: Children's Hospital of Philadelphia
Project Start Date: Sept. 5, 1997
Project End Date: March 31, 2015
FY Total Cost: $376,875

Project Title: Accelerated Protein Signaling Signatures
Contact Principal Investigator: Jacob Jaffe
Organization Name: Broad Institute
Project Start Date: April 1, 2013
Project End Date: Aug. 31, 2013
FY Total Cost: $214,747


Project Title: Analysis of Protein Dynamics in C. Elegans by MLC/MS/MS
Contact Principal Investigator: Michael MacCoss
Organization Name: University of Washington
Project Start Date: April 15, 2006
Project End Date: Nov. 30, 2013
FY Total Cost: $181,354


Project Title: A Systems Approach to Stress Biology and Proteostasis Networks
Contact Principal Investigator: Richard Morimoto
Organization Name: Northwestern University
Project Start Date: April 1, 1987
Project End Date: March 31, 2014
FY Total Cost: $489,759


Project Title: Population-Based Proteomic Investigation of Type 2 Diabetes Mellitus
Contact Principal Investigator: Randall Nelson
Organization Name: Arizona State University-Tempe Campus
Project Start Date: March 1, 2010
Project End Date: Feb. 28, 2015
FY Total Cost: $516,727


Project Title: Mitochondrial Dysfunction in Cardiac Hypertrophy and Failure
Contact Principal Investigator: Brian O'Rourke,
Organization Name: Johns Hopkins University
Project Start Date: May 1, 2010
Project End Date: March 31, 2014
FY Total Cost: $614,809


Project Title: Network Analysis of Signal Transduction
Contact Principal Investigator: Norbert Perrimon,
Organization Name: Harvard University Medical School
Project Start Date: April 15, 2010
Project End Date: March 31, 2015
FY Total Cost: $431,246


Project Title: Genetic Information Transfer to Hematopoietic Cells: Role of Microvesicles
Contact Principal Investigator: Peter Quesenberry
Organization Name: Rhode Island Hospital
Project Start Date: April 1, 2011
Project End Date: March 31, 2015
FY Total Cost: $347,625


Project Title: Mitochondrial-Targeted Antioxidants, Aging and AZT in Skeletal Muscle Dysfunction
Contact Principal Investigator: Peter Rabinovitch
Organization Name: University of Washington
Project Start Date: NA
Project End Date: NA
FY Total Cost: $273,442


Project Title: Proteomics
Contact Principal Investigator: Peter Rabinovitch
Organization Name: University of Washington
Project Start Date: NA
Project End Date: NA
FY Total Cost: $181,297


Project Title: Mitochondrial Antioxidants, Aging and Healthspan
Contact Principal Investigator: Peter Rabinovitch
Organization Name: University of Washington
Project Start Date: Aug. 15, 1997
Project End Date: Feb. 29, 2016
FY Total Cost: $1,681,304


Project Title: Cardiomyocyte Mitochondria and Mtros in Cardiac Aging, Hypertrophy and Failure
Contact Principal Investigator: Peter Rabinovitch
Organization Name: University of Washington
Project Start Date: May 1, 2010
Project End Date: March 31, 2014
FY Total Cost: $570,226


Project Title: Automated High-Throughput Estimation and Modeling of Protein Network Distributions
Contact Principal Investigator: Gustavo Rohde
Organization Name: Carnegie-Mellon University
Project Start Date: April 1, 2010
Project End Date: March 31, 2014
FY Total Cost: $266,774


Project Title: Engineered Proteases for Proteomics
Contact Principal Investigator: Biao Ruan,
Organization Name: Potomac Affinity Proteins
Project Start Date: May 1, 2009
Project End Date: Jan. 31, 2015
FY Total Cost: $339,201


Project Title: Systems Biology Facility Core
Contact Principal Investigator: James Swenberg
Organization Name: University of North Carolina Chapel Hill
Project Start Date: NA
Project End Date: NA
FY Total Cost: $178,188


Project Title: Polycomb Group Proteins as Epigenetic Mediators of Brain Ischemic Tolerance
Contact Principal Investigator: An Zhou
Organization Name: Morehouse School of Medicine
Project Start Date: April 1, 2012
Project End Date: March 31, 2016
FY Total Cost: $278,578

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.